• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

蛋白质寡聚化的机制:功能性淀粉样纤维模板抑制剂α-突触核蛋白纤维形成。

Mechanisms of protein oligomerization: inhibitor of functional amyloids templates α-synuclein fibrillation.

机构信息

Department of Chemistry, Chemical Biological Center, Umeå University, 901 87 Umeå, Sweden.

出版信息

J Am Chem Soc. 2012 Feb 22;134(7):3439-44. doi: 10.1021/ja209829m. Epub 2012 Feb 9.

DOI:10.1021/ja209829m
PMID:22260746
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3290101/
Abstract

Small organic molecules that inhibit functional bacterial amyloid fibers, curli, are promising new antibiotics. Here we investigated the mechanism by which the ring-fused 2-pyridone FN075 inhibits fibrillation of the curli protein CsgA. Using a variety of biophysical techniques, we found that FN075 promotes CsgA to form off-pathway, non-amyloidogenic oligomeric species. In light of the generic properties of amyloids, we tested whether FN075 would also affect the fibrillation reaction of human α-synuclein, an amyloid-forming protein involved in Parkinson's disease. Surprisingly, FN075 stimulates α-synuclein amyloid fiber formation as measured by thioflavin T emission, electron microscopy (EM), and atomic force microscopy (AFM). NMR data on (15)N-labeled α-synuclein show that upon FN075 addition, α-synuclein oligomers with 7 nm radius form in which the C-terminal 40 residues remain disordered and solvent exposed. The polypeptides in these oligomers contain β-like secondary structure, and the oligomers are detectable by AFM, EM, and size-exclusion chromatography (SEC). Taken together, FN075 triggers oligomer formation of both proteins: in the case of CsgA, the oligomers do not proceed to fibers, whereas for α-synuclein, the oligomers are poised to rapidly form fibers. We conclude that there is a fine balance between small-molecule inhibition and templation that depends on protein chemistry.

摘要

小分子有机化合物可以抑制功能性细菌淀粉样纤维卷曲(curli),是很有前途的新型抗生素。在此,我们研究了稠环 2-吡啶酮 FN075 抑制卷曲蛋白 CsgA 纤维形成的机制。我们使用多种生物物理技术发现,FN075 可促进 CsgA 形成非淀粉样、非纤维形成的寡聚体。鉴于淀粉样物的普遍特性,我们测试了 FN075 是否也会影响帕金森病相关的淀粉样蛋白形成蛋白人α-突触核蛋白的纤维形成反应。令人惊讶的是,FN075 可刺激α-突触核蛋白的淀粉样纤维形成,这可通过硫黄素 T 发射、电子显微镜(EM)和原子力显微镜(AFM)进行测量。对(15)N 标记的α-突触核蛋白的 NMR 数据表明,在 FN075 加入后,形成了具有 7nm 半径的α-突触核蛋白寡聚体,其中 C 末端 40 个残基保持无序并暴露于溶剂中。这些寡聚体中的多肽含有β-样二级结构,寡聚体可通过 AFM、EM 和分子筛层析(SEC)检测到。总之,FN075 触发了两种蛋白质的寡聚体形成:在 CsgA 的情况下,寡聚体不会进一步形成纤维,而对于α-突触核蛋白,寡聚体则准备快速形成纤维。我们得出结论,小分子抑制和模板之间存在微妙的平衡,这取决于蛋白质化学。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be1b/3290101/b9463c0dc5c0/ja-2011-09829m_0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be1b/3290101/8f439e551fb9/ja-2011-09829m_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be1b/3290101/16b5915e2834/ja-2011-09829m_0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be1b/3290101/4c5748995d65/ja-2011-09829m_0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be1b/3290101/b9463c0dc5c0/ja-2011-09829m_0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be1b/3290101/8f439e551fb9/ja-2011-09829m_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be1b/3290101/16b5915e2834/ja-2011-09829m_0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be1b/3290101/4c5748995d65/ja-2011-09829m_0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be1b/3290101/b9463c0dc5c0/ja-2011-09829m_0006.jpg

相似文献

1
Mechanisms of protein oligomerization: inhibitor of functional amyloids templates α-synuclein fibrillation.蛋白质寡聚化的机制:功能性淀粉样纤维模板抑制剂α-突触核蛋白纤维形成。
J Am Chem Soc. 2012 Feb 22;134(7):3439-44. doi: 10.1021/ja209829m. Epub 2012 Feb 9.
2
Direct Correlation Between Ligand-Induced α-Synuclein Oligomers and Amyloid-like Fibril Growth.配体诱导的α-突触核蛋白寡聚体与淀粉样纤维生长之间的直接相关性
Sci Rep. 2015 May 28;5:10422. doi: 10.1038/srep10422.
3
Modulation of α-synuclein fibrillization by ring-fused 2-pyridones: templation and inhibition involve oligomers with different structure.环合 2-吡啶酮对 α-突触核蛋白纤维形成的调节:模板和抑制涉及具有不同结构的低聚物。
Arch Biochem Biophys. 2013 Apr 15;532(2):84-90. doi: 10.1016/j.abb.2013.01.012. Epub 2013 Feb 9.
4
Structure-Function Analysis of the Curli Accessory Protein CsgE Defines Surfaces Essential for Coordinating Amyloid Fiber Formation.卷曲相关附属蛋白 CsgE 的结构-功能分析定义了协调淀粉样纤维形成所必需的表面。
mBio. 2018 Jul 17;9(4):e01349-18. doi: 10.1128/mBio.01349-18.
5
Mechanistic insights into accelerated α-synuclein aggregation mediated by human microbiome-associated functional amyloids.人类微生物组相关功能淀粉样蛋白介导的α-突触核蛋白加速聚集的机制见解。
J Biol Chem. 2022 Jul;298(7):102088. doi: 10.1016/j.jbc.2022.102088. Epub 2022 May 30.
6
Modulation of curli assembly and pellicle biofilm formation by chemical and protein chaperones.化学伴侣和蛋白质伴侣对卷曲菌毛组装及菌膜生物膜形成的调控
Chem Biol. 2013 Oct 24;20(10):1245-54. doi: 10.1016/j.chembiol.2013.07.017. Epub 2013 Sep 12.
7
Off-pathway oligomers of α-synuclein and Aβ inhibit secondary nucleation of α-synuclein amyloid fibrils.α-突触核蛋白和Aβ的非经典寡聚体抑制α-突触核蛋白淀粉样纤维的二次成核。
J Mol Biol. 2025 May 15;437(10):169048. doi: 10.1016/j.jmb.2025.169048. Epub 2025 Feb 25.
8
The bacterial curli system possesses a potent and selective inhibitor of amyloid formation.细菌卷曲纤维系统拥有一种有效的淀粉样蛋白形成选择性抑制剂。
Mol Cell. 2015 Feb 5;57(3):445-55. doi: 10.1016/j.molcel.2014.12.025. Epub 2015 Jan 22.
9
Smoking and Parkinson's disease: does nicotine affect alpha-synuclein fibrillation?吸烟与帕金森病:尼古丁会影响α-突触核蛋白的纤维化吗?
Biochim Biophys Acta. 2009 Feb;1794(2):282-90. doi: 10.1016/j.bbapap.2008.09.026. Epub 2008 Oct 25.
10
Crosstalk Between Alpha-Synuclein and Other Human and Non-Human Amyloidogenic Proteins: Consequences for Amyloid Formation in Parkinson's Disease.α-突触核蛋白与其他人类和非人类淀粉样蛋白原蛋白之间的串扰:帕金森病中淀粉样蛋白形成的后果。
J Parkinsons Dis. 2020;10(3):819-830. doi: 10.3233/JPD-202085.

引用本文的文献

1
Development of Positron Emission Tomography Radiotracers for Imaging α-Synuclein Aggregates.用于α-突触核蛋白聚集体成像的正电子发射断层显像剂的研发
Cells. 2025 Jun 16;14(12):907. doi: 10.3390/cells14120907.
2
Exploring the rhodanine universe: Design and synthesis of fluorescent rhodanine-based derivatives as anti-fibrillar and anti-oligomer agents against α-synuclein and 2N4R tau.探索若丹宁的世界:基于若丹宁的荧光衍生物的设计与合成,作为针对α-突触核蛋白和2N4R tau蛋白的抗纤维和抗寡聚体药物。
Bioorg Med Chem. 2024 Dec 15;116:117990. doi: 10.1016/j.bmc.2024.117990. Epub 2024 Nov 9.
3
Synthesis of Three-Dimensional Ring Fused Heterocycles by a Selective [4 + 2] Cycloaddition Between Bicyclic Thiazolo 2-Pyridones and Arynes.

本文引用的文献

1
Fibrillation of the major curli subunit CsgA under a wide range of conditions implies a robust design of aggregation.在广泛的条件下,主要卷曲亚基 CsgA 的颤动意味着聚集的稳健设计。
Biochemistry. 2011 Oct 4;50(39):8281-90. doi: 10.1021/bi200967c. Epub 2011 Sep 12.
2
Structure-based design of non-natural amino-acid inhibitors of amyloid fibril formation.基于结构的设计非天然氨基酸抑制剂抑制淀粉样纤维形成。
Nature. 2011 Jun 15;475(7354):96-100. doi: 10.1038/nature10154.
3
α-synuclein reactive antibodies as diagnostic biomarkers in blood sera of Parkinson's disease patients.
通过双环噻唑并[2,3 - b]吡啶酮与芳炔之间的选择性[4 + 2]环加成反应合成三维稠合杂环化合物
J Org Chem. 2024 Jan 5;89(1):731-739. doi: 10.1021/acs.joc.3c01957. Epub 2023 Dec 14.
4
Molecular characterization of the N-terminal half of TasA during amyloid-like assembly and its contribution to Bacillus subtilis biofilm formation.在淀粉样聚集过程中 TasA N 端结构域的分子特征及其对枯草芽孢杆菌生物膜形成的贡献。
NPJ Biofilms Microbiomes. 2023 Sep 22;9(1):68. doi: 10.1038/s41522-023-00437-w.
5
Crossroads between copper ions and amyloid formation in Parkinson's disease.铜离子与帕金森病中淀粉样形成的交叉路口。
Essays Biochem. 2022 Dec 16;66(7):977-986. doi: 10.1042/EBC20220043.
6
Identification of allosteric fingerprints of alpha-synuclein aggregates in matrix metalloprotease-1 and substrate-specific virtual screening with single molecule insights.鉴定基质金属蛋白酶-1中α-突触核蛋白聚集物的变构指纹,并利用单分子见解进行底物特异性虚拟筛选。
Sci Rep. 2022 Apr 6;12(1):5764. doi: 10.1038/s41598-022-09866-7.
7
The Small Molecule Alpha-Synuclein Aggregator, FN075, Enhances Alpha-Synuclein Pathology in Subclinical AAV Rat Models.小分子α-突触核蛋白聚集物 FN075 增强亚临床 AAV 大鼠模型中的α-突触核蛋白病理学。
Biomolecules. 2021 Nov 12;11(11):1685. doi: 10.3390/biom11111685.
8
Alpha-Synuclein PET Tracer Development-An Overview about Current Efforts.α-突触核蛋白正电子发射断层显像示踪剂的研发——当前研究进展概述
Pharmaceuticals (Basel). 2021 Aug 26;14(9):847. doi: 10.3390/ph14090847.
9
Macromolecular crowding modulates α-synuclein amyloid fiber growth.大分子拥挤调节α-突触核蛋白淀粉样纤维的生长。
Biophys J. 2021 Aug 17;120(16):3374-3381. doi: 10.1016/j.bpj.2021.06.032. Epub 2021 Jul 7.
10
Anti-Biofilm Molecules Targeting Functional Amyloids.靶向功能性淀粉样蛋白的抗生物膜分子。
Antibiotics (Basel). 2021 Jun 29;10(7):795. doi: 10.3390/antibiotics10070795.
α-突触核蛋白反应性抗体作为帕金森病患者血清中的诊断生物标志物。
PLoS One. 2011 Apr 25;6(4):e18513. doi: 10.1371/journal.pone.0018513.
4
Inhibition and disaggregation of α-synuclein oligomers by natural polyphenolic compounds.天然多酚化合物对α-突触核蛋白寡聚物的抑制和解聚作用。
FEBS Lett. 2011 Apr 20;585(8):1113-20. doi: 10.1016/j.febslet.2011.03.046. Epub 2011 Mar 31.
5
In vivo demonstration that alpha-synuclein oligomers are toxic.体内实验证明α-突触核蛋白寡聚体具有毒性。
Proc Natl Acad Sci U S A. 2011 Mar 8;108(10):4194-9. doi: 10.1073/pnas.1100976108. Epub 2011 Feb 15.
6
Low-resolution structure of a vesicle disrupting α-synuclein oligomer that accumulates during fibrillation.在纤维形成过程中积累的囊泡破坏α-突触核蛋白寡聚物的低分辨率结构。
Proc Natl Acad Sci U S A. 2011 Feb 22;108(8):3246-51. doi: 10.1073/pnas.1013225108. Epub 2011 Feb 7.
7
The anti-Parkinsonian drug selegiline delays the nucleation phase of α-synuclein aggregation leading to the formation of nontoxic species.抗帕金森病药物司来吉兰可延迟α-突触核蛋白聚集的成核阶段,从而形成无毒的物种。
J Mol Biol. 2011 Jan 7;405(1):254-73. doi: 10.1016/j.jmb.2010.10.027. Epub 2010 Nov 2.
8
Seeded aggregation and toxicity of {alpha}-synuclein and tau: cellular models of neurodegenerative diseases.α-突触核蛋白和 Tau 的种子聚集和毒性:神经退行性疾病的细胞模型。
J Biol Chem. 2010 Nov 5;285(45):34885-98. doi: 10.1074/jbc.M110.148460. Epub 2010 Aug 30.
9
Strategies to increase the reproducibility of protein fibrillization in plate reader assays.提高平板读数仪检测中蛋白质纤维形成重现性的策略。
Anal Biochem. 2010 May 15;400(2):270-81. doi: 10.1016/j.ab.2010.02.001. Epub 2010 Feb 10.
10
Accelerated formation of alpha-synuclein oligomers by concerted action of the 20S proteasome and familial Parkinson mutations.协同作用 20S 蛋白酶体和家族性帕金森病突变加速α-突触核蛋白寡聚体的形成。
J Bioenerg Biomembr. 2010 Feb;42(1):85-95. doi: 10.1007/s10863-009-9258-y. Epub 2010 Feb 11.